Hyperlipidaemia of sufficient severity to cause symptoms and signs in childhood is a rare occurrence. The "commonest" rare cause is homozygous familial hypercholesterolaemia (FH), with a frequency of one in a million, which gives rise to cutaneous and tendon xanthomas, corneal arcus, and atherosclerotic involvement of the aorta and coronary arteries by the age of 15.' Equally rare are children with inherited deficiency of lipoprotein lipase (type I hyperlipidaemia) who present with attacks of acute pancreatitis and severe hypertriglyceridaemia, sometimes accompanied by eruptive xanthomas. Rarer still are those manifesting mixed hyperlipidaemia and palmar striae (type III hyperlipidaemia), the expression of which in childhood indicates an underlying dominant mutation of the apolipoprotein E gene. 2 The most commonly recognised and best understood cause of inherited hyperlipidaemia in childhood is heterozygous FH, which has a prevalence of 0'2% in most populations. This is usually asymptomatic until adult life and pathognomonic tendon xanthomas develop in very few cases before the age of 19.3 However, there is a steep increase in both the prevalence of tendon xanthomas and the incidence of fatal coronary heart disease (CHD) between the ages of 20 and 39.4 It seems reasonable to speculate that lipid-lowering treatment during adolescence would reduce this risk.
Association between dyslipidaemia and atherosclerosis in youth There is convincing pathological evidence that atherosclerosis starts by the age of 6 and is commonly associated with abnormalities of serum lipids, albeit less marked than those which occur in FH. In both the PDAY5 6 and Bogalusa7 studies about a fifth of children and young adults dying suddenly from non-cardiac causes showed evidence of coronary and aortic atherosclerosis, especially the latter. The severity of lesions was more marked in males and in those who were smokers. Fatty streaks were the commonest finding but raised lesions occurred in the abdominal aorta and right coronary artery in a minority of those aged 15- (NCEP) in the USA were that all children and adolescents over the age of two should limit their intake of total and saturated fat to not more than 30% and 10% respectively of total calories and dietary cholesterol to less than 300 mg/day.9
Screening for cardiovascular risk during childhood Studies of 63 families where the father had developed CHD by the age of 50 showed increased concentrations of triglyceride or LDL cholesterol and/or decreased concentrations of HDL cholesterol in 65% of affected fathers and 51% of their children.'0 Similar results were obtained in a study of over 800 adolescents in whom serum cholesterol, triglyceride, and apolipoprotein B concentrations were higher in boys with a family history of death from myocardial infarction before the age of 55 and in girls with a paternal history of a cerebrovascular accident.8
These findings suggest that early detection of children at increased risk of developing CHD in adult life on account of inherited or acquired familial traits is feasible by selective screening, as promulgated by the NCEP. 9 Specific recommendations were to measure serum cholesterol in all children whose parents or grandparents developed evidence of CHD before the age of 55, or where one of the parents has a serum cholesterol of > 6-2 mmol/l. 
